DNA mismatch repair system regulates the expression of PD-L1 through DNMTs in cervical cancer
Abstract Background Cervical cancer (CC) is a potential clinical application of PD-1/PD-L1 inhibitor. We aimed to study the mechanism of DNA mismatch repair (MMR) system regulating the expression of PD-L1 in CC through DNA methyltransferase (DNMTs). Methods We collected pathological specimens from 1...
Main Authors: | Fan Guo, Ruijiao Lu, Weina Kong, Miyessar Anwar, Yangchun Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-024-03214-7 |
Similar Items
-
The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance
by: Feng YC, et al.
Published: (2018-01-01) -
DNA Mismatch Repair Assessment in Gastric and Colon Cancers Using Stochastic Microdisks
by: Prof. Dr. Raluca‐Ioana Stefan‐van Staden, et al.
Published: (2023-11-01) -
A rapid, simple DNA mismatch repair substrate construction method
by: Timothy James Kinsella, et al.
Published: (2011-06-01) -
DNA Mismatch Repair and Oxidative DNA Damage: Implications for Cancer Biology and Treatment
by: Gemma Bridge, et al.
Published: (2014-08-01) -
Association of clinicopathological features with DNA mismatch repair status among colorectal cancer patients presenting to a Tertiary Care Cancer Hospital
by: Gayathri G Nair, et al.
Published: (2022-01-01)